1. Home
  2. SLS vs VABK Comparison

SLS vs VABK Comparison

Compare SLS & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • VABK
  • Stock Information
  • Founded
  • SLS 2012
  • VABK 1998
  • Country
  • SLS United States
  • VABK United States
  • Employees
  • SLS N/A
  • VABK N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • VABK Major Banks
  • Sector
  • SLS Health Care
  • VABK Finance
  • Exchange
  • SLS Nasdaq
  • VABK Nasdaq
  • Market Cap
  • SLS 169.6M
  • VABK 199.2M
  • IPO Year
  • SLS N/A
  • VABK N/A
  • Fundamental
  • Price
  • SLS $1.85
  • VABK $38.06
  • Analyst Decision
  • SLS
  • VABK
  • Analyst Count
  • SLS 0
  • VABK 0
  • Target Price
  • SLS N/A
  • VABK N/A
  • AVG Volume (30 Days)
  • SLS 3.6M
  • VABK 4.9K
  • Earning Date
  • SLS 08-12-2025
  • VABK 07-18-2025
  • Dividend Yield
  • SLS N/A
  • VABK 3.86%
  • EPS Growth
  • SLS N/A
  • VABK 3.77
  • EPS
  • SLS N/A
  • VABK 3.30
  • Revenue
  • SLS N/A
  • VABK $54,953,000.00
  • Revenue This Year
  • SLS N/A
  • VABK N/A
  • Revenue Next Year
  • SLS N/A
  • VABK N/A
  • P/E Ratio
  • SLS N/A
  • VABK $11.67
  • Revenue Growth
  • SLS N/A
  • VABK 1.60
  • 52 Week Low
  • SLS $0.77
  • VABK $32.16
  • 52 Week High
  • SLS $2.27
  • VABK $44.00
  • Technical
  • Relative Strength Index (RSI)
  • SLS 52.48
  • VABK 57.74
  • Support Level
  • SLS $1.88
  • VABK $37.48
  • Resistance Level
  • SLS $2.27
  • VABK $38.51
  • Average True Range (ATR)
  • SLS 0.17
  • VABK 0.54
  • MACD
  • SLS -0.00
  • VABK 0.14
  • Stochastic Oscillator
  • SLS 52.60
  • VABK 96.41

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

Share on Social Networks: